Bortezomib‐induced pro‐inflammatory macrophages as a potential factor limiting anti‐tumour efficacy
Ofrat Beyar‐Katz(Rambam Health Care Campus), Yuval Shaked(Technion – Israel Institute of Technology), Yosef Yarden(Weizmann Institute of Science), Ksenia Magidey(Rappaport Family Institute for Research in the Medical Sciences), Valeria Miller(Rappaport Family Institute for Research in the Medical Sciences), Dror Alishekevitz(Technion – Israel Institute of Technology), Neta Ben-Tsedek(Technion – Israel Institute of Technology), Michael Timaner(Technion – Israel Institute of Technology), Irit Avivi(Tel Aviv Sourasky Medical Center), Moshit Lindzen(Weizmann Institute of Science)
Cited by 25
Related Papers
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
|Genes & Development|1998|861
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
The basic biology of HER2
|Annals of Oncology|2001|500
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
|Blood Advances|2021|170
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
|Transplantation and Cellular Therapy|2021|164